These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9677010)

  • 1. Epstein-Barr virus infections and their association with human malignancies: some key questions.
    Griffin BE; Xue SA
    Ann Med; 1998 Jun; 30(3):249-59. PubMed ID: 9677010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells.
    Sugiura M; Imai S; Tokunaga M; Koizumi S; Uchizawa M; Okamoto K; Osato T
    Br J Cancer; 1996 Aug; 74(4):625-31. PubMed ID: 8761381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune regulation in Epstein-Barr virus-associated diseases.
    Khanna R; Burrows SR; Moss DJ
    Microbiol Rev; 1995 Sep; 59(3):387-405. PubMed ID: 7565411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.
    Klein G; Klein E; Kashuba E
    Biochem Biophys Res Commun; 2010 May; 396(1):67-73. PubMed ID: 20494113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus (EBV) and human disease: facts, opinions and problems.
    Griffin BE
    Mutat Res; 2000 Apr; 462(2-3):395-405. PubMed ID: 11523539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus and oncogenesis: from latent genes to tumours.
    Young LS; Murray PG
    Oncogene; 2003 Aug; 22(33):5108-21. PubMed ID: 12910248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ecology and pathology of Epstein-Barr virus.
    Schmidt CW; Misko IS
    Immunol Cell Biol; 1995 Dec; 73(6):489-504. PubMed ID: 8713470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel hypotheses for the roles of EBNA-1 and BHRF1 in EBV-related cancers.
    Horner D; Lewis M; Farrell PJ
    Intervirology; 1995; 38(3-4):195-205. PubMed ID: 8682617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus: 40 years on.
    Young LS; Rickinson AB
    Nat Rev Cancer; 2004 Oct; 4(10):757-68. PubMed ID: 15510157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus provides a survival factor to Burkitt's lymphomas.
    Kennedy G; Komano J; Sugden B
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14269-74. PubMed ID: 14603034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells.
    Cuomo L; Trivedi P; de Grazia U; Calogero A; D'Onofrio M; Yang W; Frati L; Faggioni A; Rymo L; Ragona G
    J Med Virol; 1998 Jul; 55(3):219-26. PubMed ID: 9624610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-encoded microRNAs as regulators in host immune responses.
    Wang M; Yu F; Wu W; Wang Y; Ding H; Qian L
    Int J Biol Sci; 2018; 14(5):565-576. PubMed ID: 29805308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma.
    Shah KM; Young LS
    Clin Microbiol Infect; 2009 Nov; 15(11):982-8. PubMed ID: 19874382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.
    Niedobitek G
    Mol Pathol; 2000 Oct; 53(5):248-54. PubMed ID: 11091848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant-negative derivative of EBNA1 represses EBNA1-mediated transforming gene expression during the acute phase of Epstein-Barr virus infection independent of rapid loss of viral genome.
    Kariya Y; Hamatake M; Urano E; Yoshiyama H; Shimizu N; Komano J
    Cancer Sci; 2010 Apr; 101(4):876-81. PubMed ID: 20132216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy for Epstein-Barr virus-associated cancers in children.
    Straathof KC; Bollard CM; Rooney CM; Heslop HE
    Oncologist; 2003; 8(1):83-98. PubMed ID: 12604735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma.
    Niedobitek G; Agathanggelou A; Nicholls JM
    Semin Cancer Biol; 1996 Aug; 7(4):165-74. PubMed ID: 8946600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biology and chemistry of Epstein-Barr virus.
    Kieff E; Dambaugh T; Heller M; King W; Cheung A; van Santen V; Hummel M; Beisel C; Fennewald S; Hennessy K; Heineman T
    J Infect Dis; 1982 Oct; 146(4):506-17. PubMed ID: 6288806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell recognition of Epstein-Barr virus associated lymphomas.
    Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
    Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus persistence and virus-associated tumours.
    Niedobitek G; Young LS
    Lancet; 1994 Feb; 343(8893):333-5. PubMed ID: 7905149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.